These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 38538256

  • 1. A Novel Cholesterol Metabolism-Related lncRNA Signature Predicts the Prognosis of Patients with Hepatocellular Carcinoma and Their Response to Immunotherapy.
    Lei H, Xiang T, Zhu H, Hu X.
    Front Biosci (Landmark Ed); 2024 Mar 22; 29(3):129. PubMed ID: 38538256
    [Abstract] [Full Text] [Related]

  • 2. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S, Bai H, Fei S, Miao B.
    Biochem Genet; 2024 Jun 22; 62(3):2332-2351. PubMed ID: 37898914
    [Abstract] [Full Text] [Related]

  • 3. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y, Wei X, Han Q, Le J, Ma Y, Lin X, Xu Y, Liu N, Wang X, Kong X, Gu J, Tong Y, Wu H.
    BMC Cancer; 2021 Oct 30; 21(1):1165. PubMed ID: 34717566
    [Abstract] [Full Text] [Related]

  • 4. A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma.
    Liu Y, Jiang J.
    Cancer Biomark; 2023 Oct 30; 37(1):13-26. PubMed ID: 37005878
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification.
    Yang C, Zhang L, Hao X, Tang M, Zhou B, Hou J.
    Curr Oncol; 2022 Dec 28; 30(1):430-448. PubMed ID: 36661684
    [Abstract] [Full Text] [Related]

  • 7. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ, Zhang J, Xu L, Liu FF.
    World J Gastroenterol; 2018 Aug 14; 24(30):3426-3439. PubMed ID: 30122881
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
    Xu Q, Wang Y, Huang W.
    Int Immunopharmacol; 2021 Mar 14; 92():107333. PubMed ID: 33486322
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma.
    Zhu J, Huang Q, Liu S, Peng X, Xue J, Feng T, Huang W, Chen Z, Lai K, Ji Y, Wang M, Yuan R.
    Front Immunol; 2022 Mar 14; 13():856186. PubMed ID: 35479067
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma.
    Liu C, Wu S, Lai L, Liu J, Guo Z, Ye Z, Chen X.
    BMC Bioinformatics; 2023 Jan 03; 24(1):4. PubMed ID: 36597032
    [Abstract] [Full Text] [Related]

  • 15. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
    Wang X, Qian J, Yao N, Pocha C, Kang KJ, Angelico R, Zhu G.
    Ann Transl Med; 2022 May 03; 10(10):595. PubMed ID: 35722420
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of a DNA damage repair-related LncRNA signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma.
    Huang F, Zhang C, Yang W, Zhou Y, Yang Y, Yang X, Guo W, Wang B.
    BMC Genomics; 2024 Feb 08; 25(1):155. PubMed ID: 38326754
    [Abstract] [Full Text] [Related]

  • 18. Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma.
    Li R, Jin C, Zhao W, Liang R, Xiong H.
    BMC Gastroenterol; 2022 Nov 07; 22(1):450. PubMed ID: 36344926
    [Abstract] [Full Text] [Related]

  • 19. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
    Huang S, Zhang J, Lai X, Zhuang L, Wu J.
    Front Mol Biosci; 2021 Nov 07; 8():781307. PubMed ID: 35004851
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.